Cargando…
“Therapeutic” facemasks
There must be pathophysiological reason why “cold” viruses like SARS-CoV-2 show proclivity to nasal cavity, oral cavity, pharyngeal cavity and upper airways which have lower temperature than core body temperature. Henceforth, facemasks’ “therapeutic” role against SARS-CoV-2 must be explored because...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236693/ https://www.ncbi.nlm.nih.gov/pubmed/32460210 http://dx.doi.org/10.1016/j.mehy.2020.109855 |
_version_ | 1783536195013181440 |
---|---|
author | Gupta, Deepak |
author_facet | Gupta, Deepak |
author_sort | Gupta, Deepak |
collection | PubMed |
description | There must be pathophysiological reason why “cold” viruses like SARS-CoV-2 show proclivity to nasal cavity, oral cavity, pharyngeal cavity and upper airways which have lower temperature than core body temperature. Henceforth, facemasks’ “therapeutic” role against SARS-CoV-2 must be explored because personal “therapeutic” environments may get created under facemasks due to rebreathing of ~95°F “hot” and ~80% “humid” exhalations which may constantly mitigate SARS-CoV-2 inside nasal cavity, oral cavity, pharyngeal cavity and upper airways. |
format | Online Article Text |
id | pubmed-7236693 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72366932020-05-19 “Therapeutic” facemasks Gupta, Deepak Med Hypotheses Letter to Editors There must be pathophysiological reason why “cold” viruses like SARS-CoV-2 show proclivity to nasal cavity, oral cavity, pharyngeal cavity and upper airways which have lower temperature than core body temperature. Henceforth, facemasks’ “therapeutic” role against SARS-CoV-2 must be explored because personal “therapeutic” environments may get created under facemasks due to rebreathing of ~95°F “hot” and ~80% “humid” exhalations which may constantly mitigate SARS-CoV-2 inside nasal cavity, oral cavity, pharyngeal cavity and upper airways. Elsevier Ltd. 2020-10 2020-05-19 /pmc/articles/PMC7236693/ /pubmed/32460210 http://dx.doi.org/10.1016/j.mehy.2020.109855 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to Editors Gupta, Deepak “Therapeutic” facemasks |
title | “Therapeutic” facemasks |
title_full | “Therapeutic” facemasks |
title_fullStr | “Therapeutic” facemasks |
title_full_unstemmed | “Therapeutic” facemasks |
title_short | “Therapeutic” facemasks |
title_sort | “therapeutic” facemasks |
topic | Letter to Editors |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236693/ https://www.ncbi.nlm.nih.gov/pubmed/32460210 http://dx.doi.org/10.1016/j.mehy.2020.109855 |
work_keys_str_mv | AT guptadeepak therapeuticfacemasks |